Experience with long-term use of certolizumab pegol (Cimzia)
<p>Objective: to establish whether long-term combination therapy with a tumor necrosis factor (TNF) α inhibitor and a disease-modifying antirheumatic drug (DMARD) (methotrexate – MTX) may lead to sustained rheumatoid arthritis (RA) remission and its maintenance even after discontinuation of ge...
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Alt |
| Teanga: | Russian |
| Foilsithe / Cruthaithe: |
IMA-PRESS LLC
2013-10-01
|
| Sraith: | Современная ревматология |
| Ábhair: | |
| Rochtain ar líne: | http://mrj.ima-press.net/index.php/mrj/article/view/496 |